指南与共识胃肠外科围术期管理与 ERAS

EAES快速指南:减重手术的系统评价、网状Meta分析与欧洲共识(2022扩展版)

EAES rapid guideline: systematic review, network meta-analysis, CINeMA and GRADE assessment, and European consensus on bariatric surgery-extension 2022.
指南 / 共识 · Surg Endosc · 2022-01-20

欧洲内镜外科协会减重指南组针对7种成人腹腔镜减重术式,基于24项RCT(43条记录)的系统评价与网状Meta分析,采用CINeMA和GRADE评估证据确定性,经Delphi共识形成推荐。建议对重度肥胖及代谢病优先选择袖状胃或Roux-en-Y胃旁路,而非可调节胃束带、胆胰分流十二指肠转位或胃折叠;单吻合口胃旁路和SADI-S可作为替代,但证据有限。

要点

  • 对重度肥胖及代谢病,建议袖状胃或腹腔镜Roux-en-Y胃旁路优于可调节胃束带、胆胰分流十二指肠转位和胃折叠。
  • 单吻合口胃旁路和SADI-S可作为替代术式,但获益与危害及选择标准的证据较袖状胃和Roux-en-Y胃旁路有限。
  • 本指南替代EAES 2020减重指南中的相关推荐。

核心结论

  • 在考虑证据确定性和证据到决策参数后,建议对重度肥胖及相关代谢病选择袖状胃或腹腔镜Roux-en-Y胃旁路,而非可调节胃束带、胆胰分流十二指肠转位或胃折叠。

研究设计与样本

  • 欧洲多学科小组(含普外科医师、肥胖医师、麻醉医师、心理师和患者代表)确定结局重要性和最小重要差异。
  • 系统评价与频率学固定及随机效应网状Meta分析纳入24项RCT(43条记录),采用图论法,二分类结局计算OR、连续结局计算(标准化)均数差及95%CI。
  • 采用CINeMA和GRADE评估证据确定性,在GRADE证据到决策框架下形成推荐,并经匿名Delphi流程验证。

主要发现

  • 多数网状信息围绕袖状胃和Roux-en-Y胃旁路。
  • 单吻合口胃旁路和SADI-S被建议作为替代方案,但获益与危害及具体选择标准的证据较袖状胃和Roux-en-Y胃旁路有限。

关键数值与推荐

  • 建议对重度肥胖及相关代谢病选择袖状胃或腹腔镜Roux-en-Y胃旁路,而非可调节胃束带、胆胰分流十二指肠转位和胃折叠。
  • 单吻合口胃旁路和SADI-S可作为替代方案,但证据有限。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The European Association for Endoscopic Surgery Bariatric Guidelines Group identified a gap in bariatric surgery recommendations with a structured, contextualized consideration of multiple bariatric interventions. OBJECTIVE: To provide evidence-informed, transparent and trustworthy recommendations on the use of sleeve gastrectomy, Roux-en-Y gastric bypass, adjustable gastric banding, gastric plication, biliopancreatic diversion with duodenal switch, one anastomosis gastric bypass, and single anastomosis duodeno-ileal bypass with sleeve gastrectomy in patients with severe obesity and metabolic diseases. Only laparoscopic procedures in adults were considered. METHODS: A European interdisciplinary panel including general surgeons, obesity physicians, anesthetists, a psychologist and a patient representative informed outcome importance and minimal important differences. We conducted a systematic review and frequentist fixed and random-effects network meta-analysis of randomized-controlled trials (RCTs) using the graph theory approach for each outcome. We calculated the odds ratio or the (standardized) mean differences with 95% confidence intervals for binary and continuous outcomes, respectively. We assessed the certainty of evidence using the CINeMA and GRADE methodologies. We considered the risk/benefit outcomes within a GRADE evidence to decision framework to arrive at recommendations, which were validated through an anonymous Delphi process of the panel. RESULTS: We identified 43 records reporting on 24 RCTs. Most network information surrounded sleeve gastrectomy and Roux-en-Y gastric bypass. Under consideration of the certainty of the evidence and evidence to decision parameters, we suggest sleeve gastrectomy or laparoscopic Roux-en-Y gastric bypass over adjustable gastric banding, biliopancreatic diversion with duodenal switch and gastric plication for the management of severe obesity and associated metabolic diseases. One anastomosis gastric bypass and single anastomosis duodeno-ileal bypass with sleeve gastrectomy are suggested as alternatives, although evidence on benefits and harms, and specific selection criteria is limited compared to sleeve gastrectomy and Roux-en-Y gastric bypass. The guideline, with recommendations, evidence summaries and decision aids in user friendly formats can also be accessed in MAGICapp: https://app.magicapp.org/#/guideline/Lpv2kE CONCLUSIONS: This rapid guideline provides evidence-informed, pertinent recommendations on the use of bariatric and metabolic surgery for the management of severe obesity and metabolic diseases. The guideline replaces relevant recommendations published in the EAES Bariatric Guidelines 2020.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Carrano FM, Iossa A, Di Lorenzo N, et al. EAES rapid guideline: systematic review, network meta-analysis, CINeMA and GRADE assessment, and European consensus on bariatric surgery-extension 2022. Surg Endosc. 2022. PMID: 35059839. doi:10.1007/s00464-022-09008-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。